All posts by Amber Dance

ALS, PARP Diem?

Could a cancer medicine targeting PARPs potentially be repurposed as a therapy for ALS? A new study suggests its a possibility.

Read more »


Meeting ALS at the Junction

Motor neurons, and methods to protect them, get much of the attention in ALS. But there’s something that goes wrong before motor neurons degenerate: their axons detach from muscle fibers, noted J. Hickman of the University of Central Florida (UCF) in Orlando: “We believe that the initial disease pathology occurs at the neuromuscular junction.” Worth […]

Read more »